Fed’s Powell opens door to potential rate cuts at Jackson Hole
CHICAGO—John McCartney, a director at Huron Consulting Group Inc. (NASDAQ:HURN), has sold 500 shares of the company’s common stock, according to a recent SEC filing. The shares were sold at a price of $151.13 each, amounting to a total transaction value of $75,565. The transaction comes as Huron’s stock has delivered an impressive 51.7% return over the past year, trading near its 52-week high of $153.85.
This sale was conducted automatically under a pre-established Rule 10b5-1 trading plan that McCartney adopted on August 15, 2024. Following the transaction, McCartney retains ownership of 55,688 shares of Huron Consulting Group. According to InvestingPro data, the company maintains a GREAT financial health score, while management has been actively buying back shares.
Investors often monitor insider transactions like these for insights into the company’s future prospects and the executive’s confidence in the company’s performance. InvestingPro subscribers can access 12 additional key insights and comprehensive insider trading analysis in the Pro Research Report, helping investors make more informed decisions.
In other recent news, Huron Consulting Group has reported strong financial results for the fourth quarter of 2024, with earnings per share (EPS) of $1.90, surpassing analyst expectations of $1.52. The company’s revenue for the quarter reached $399.31 million, exceeding the consensus estimate of $379.99 million. For the full year 2024, Huron achieved record revenues of $1.49 billion, marking a 9.1% increase from the previous year. In light of these results, Truist Securities and Benchmark have both raised their price targets for Huron to $165, maintaining a Buy rating.
Truist Securities analyst Tobey Sommer has also increased the price target to $180, citing expectations for accelerated growth in Huron’s core markets, particularly healthcare and higher education. Sommer anticipates that changes in federal spending could benefit Huron, with potential increases in large-scale projects at academic medical centers and heightened demand for performance improvement services at hospitals. Benchmark analyst Bill Sutherland highlighted Huron’s potential in the healthcare sector, noting possible changes in clinical reimbursement models and other strategic initiatives. Huron’s guidance for 2025 forecasts an EPS range of $6.80-$7.60 and revenue projections between $1.58 billion and $1.66 billion, aligning closely with consensus estimates.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.